Avelumab–cetuximab–radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH)

Phase Iii Trial

Phase III trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck

http://isrctn.org/> ◽

10.1186/isrctn52466525 ◽

2012 ◽

Author(s):

Jose Luis Aguilar Ponce

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Phase Iii ◽

Phase Iii Trial

LBA35 Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial

Annals of Oncology ◽

10.1016/j.annonc.2021.08.2112 ◽

2021 ◽

Vol 32 ◽

pp. S1310

Author(s):

J. Bourhis ◽

Y. Tao ◽

X. Sun ◽

C. Sire ◽

L. Martin ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Phase Iii ◽

Standards Of Care ◽

Advanced Squamous Cell Carcinoma

910O Primary results of the phase III JAVELIN head & neck 100 trial: Avelumab plus chemoradiotherapy (CRT) followed by avelumab maintenance vs CRT in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1025 ◽

2020 ◽

Vol 31 ◽

pp. S658 ◽

Cited By ~ 1

Author(s):

E.E. Cohen ◽

R.L. Ferris ◽

A. Psyrri ◽

R. Haddad ◽

M. Tahara ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Phase Iii ◽

Head Neck

Randomized phase III trial in locally advanced squamous cell carcinoma of the esophagus: Neoadjuvant radiochemotherapy followed by surgery vs. definitive radiochemotherapy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(04)01100-9 ◽

2004 ◽

Vol 60 ◽

pp. S139-S139 ◽

Cited By ~ 1

Author(s):

M STUSCHKE ◽

M STAHL ◽

H WILKE ◽

M WALZ ◽

S SEEBER ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Locally Advanced ◽

Phase Iii ◽

Neoadjuvant Radiochemotherapy ◽

Carcinoma Of The Esophagus ◽

Phase Iii Trial ◽

Definitive Radiochemotherapy

Standard cisplatin/infusional 5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cell carcinoma of the head andneck (LA-SCCHN): a phase III trial of the EORTC Head and Neck Cancer Group (EORTC #24971)

10.1200/jco.2004.22.14_suppl.5508 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 5508-5508 ◽

Cited By ~ 27

Author(s):

J. B. Vermorken ◽

E. Remenar ◽

C. van Herpen ◽

J. Germa Lluch ◽

S. Stewart ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Head And Neck Cancer ◽

Neoadjuvant Chemotherapy ◽

Cell Carcinoma ◽

Head And Neck ◽

Locally Advanced ◽

Phase Iii ◽

Phase Iii Trial ◽

Cancer Group

Standard cisplatin/infusional 5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cell carcinoma of the head andneck (LA-SCCHN): a phase III trial of the EORTC Head and Neck Cancer Group (EORTC #24971)

10.1200/jco.2004.22.90140.5508 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 5508-5508 ◽

Cited By ~ 8

Author(s):

J. B. Vermorken ◽

E. Remenar ◽

C. van Herpen ◽

J. Germa Lluch ◽

S. Stewart ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Head And Neck Cancer ◽

Neoadjuvant Chemotherapy ◽

Cell Carcinoma ◽

Head And Neck ◽

Locally Advanced ◽

Phase Iii ◽

Phase Iii Trial ◽

Cancer Group

Results of a randomized phase III study of nimotuzumab in combination with concurrent radiotherapy and cisplatin versus radiotherapy and cisplatin alone, in locally advanced squamous cell carcinoma of the head and neck.

10.1200/jco.2018.36.15_suppl.6000 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 6000-6000 ◽

Cited By ~ 3

Author(s):

Vijay Maruti Patil ◽

Vanita Noronha ◽

Amit Joshi ◽

Jaiprakash Agarwal ◽

Sarbani Ghosh Laskar ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Phase Iii ◽

Concurrent Radiotherapy ◽

Phase Iii Study

Concomitant chemoradiation (CRT) or cetuximab/RT (CET/RT) versus induction Docetaxel/ Cisplatin/5-Fluorouracil (TPF) followed by CRT or CET/RT in patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN). A randomized phase III factorial study (NCT01086826).

10.1200/jco.2014.32.15_suppl.6004 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 6004-6004 ◽

Cited By ~ 29

Author(s):

Maria Grazia Ghi ◽

Adriano Paccagnella ◽

Daris Ferrari ◽

Paolo Foa ◽

Maria Cossu Rocca ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Phase Iii ◽

Concomitant Chemoradiation

Avelumab-cetuximab-radiotherapy versus standards of care (SoC) in patients (pts) with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Safety phase of randomized trial GORTEC 2017-01 (REACH)

Annals of Oncology ◽

10.1093/annonc/mdz252.010 ◽

2019 ◽

Vol 30 ◽

pp. v454

Author(s):

Y. Tao ◽

A. Auperin ◽

X. Sun ◽

C. Sire ◽

L. Martin ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Randomized Trial ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Standards Of Care ◽

Advanced Squamous Cell Carcinoma

327 oral Randomized phase III trial in locally advanced squamous cell carcinoma of the esophagus: neoadjuvant radiochemotherapy followed by surgery vs. definitive radiochemotherapy

Radiotherapy and Oncology ◽

10.1016/s0167-8140(04)82193-5 ◽

2004 ◽

Vol 73 ◽

pp. S148

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Locally Advanced ◽

Phase Iii ◽

Neoadjuvant Radiochemotherapy ◽

Carcinoma Of The Esophagus ◽

Phase Iii Trial ◽

Definitive Radiochemotherapy